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Objectives. In view of the segmental occurrence of coronary 
atherosclerosis, we postulated that acetylcholine may cause het- 
erogeneous vasomotion, depending on the extent of vessel ana- 
lyzed, criteria for change in vessel caliber and dose of drug 
administered. 
Background. Previous studies have reported that acetylcholine 
causes constriction of atherosclerotic arteries. This dysfunction of 
endothelium-dependent dilation may be seen without angio- 
graphically detectable disease. 
Methods. We developed algorithms to quantitate the dimen- 
sions of a single coronary artery over virtually its entire length 
during a control state and during graded doses of intracoronary 
acetylcholine. On the basis of triplicate control angiograms, the 
limit of detection of a change from control diameter was 0.31 mm 
(>2 SD). 
Results. Analysis of multiple segments (each 5.6 -+ 1.1 [mean -+ 
SD] ram) along a single coronary artery revealed a heterogeneous 
response to acetylcholine in 27 of 31 patients at the 10 -4 mol/liter 
dose and in 29 of 31 patients when responses at 10 -6, 10 -s and 
10 -4  mol/liter doses were combined; in this latter analysis, 
constriction and dilation in the same vessel occurred in 45% of the 
patients. With acetylcholine, most of 349 segments demonstrated 
no change, but the greatest frequency of vasoconstriction (24.6%) 
and vasodilation (6.9%) was seen at the 10 -4  tool/liter dose. 
Inducible vasomotion was observed as far distally as 7.3 em from 
the site of acetylcholine infusion. 
Conclusions. Response to intracoronary acetylcholine with mild 
coronary disease is heterogeneous; disparate dimensional re- 
sponses may occur in different segments of the same vessel. 
Inclusion of all analyzable regions of a coronary artery and the 
use of a reproducibility limit for quantitative angiography are 
optimal for assessment of segmental coronary vasomotion. 
(J Am Coll Cardiol 1995;25:1046-55) 
After the observation by Ludmer et al. (1) that acetylcholine 
causes paradoxic vasoconstriction f atherosclerotic coronary 
arteries in humans, others (2-5) have observed that both mild 
and severe degrees of atherosclerosis are associated with 
dysfunction of endothelium-dependent vasodilation. Impair- 
ment of this normal physiologic function has also been corre- 
lated with elevated serum cholesterol, family history of coro- 
nary artery disease, hypertension, male gender, age and 
enhanced sensitivity to the vasoconstrictor effects of cat- 
echolamines (6-11). Further, in subjects with significant risk 
factors for coronary disease, endothelium-dependent ila ion 
of coronary arteries is compromised before changes in intimal 
morphology are seen by intravascular ultrasound (12). An 
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abnormal, vasoconstrictor response to acetylcholine is partic- 
ularly prone to occur in the proximal segment of the artery as 
well as at branch points (13). Some investigators have sug- 
gested that endothelial-dependent vasodilator dysfunction oc- 
curs in a hierarchic fashion, with acetylcholine and serotonin 
dilator responses becoming impaired before flow-mediated 
dilation or the dilator responses to complex sympathetic 
stimuli, such as cold exposure (14). 
In view of the segmental occurrence of coronary atheroscle- 
rosis, we postulated that in any given coronary artery there may 
be a relatively heterogeneous vasomotor esponse to the 
administration f acetylcholine, depending on the region and 
extent of the vessel analyzed. Moreover, the reproducibility of 
serial measurements could affect the categorization of an 
individual patient or individual arterial segment as one that 
demonstrates coronary dilation or constriction. 
Accordingly, we developed cineangiographic processing 
methods aimed at quantitating the dimensions of a coronary 
artery over virtually its entire length. To maximize correspon- 
dence of diameter measurements from multiple sequential 
contrast injections, fiducial oci based on branch points were 
utilized to interpolate any pharmacologically stimulated artery 
against its control injection. These computer algorithms were 
then applied to subjects with mild degrees of obstructive 
©1995 by the American College of CardioloKy 0735-1097/95/$9.50 
0735-1097(94)00537-Z 
JACC Vol. 25, No. 5 PENNY ET AL. 1047 
April 1995:1046-55 CORONARY ARTERY RESPONSE TO ACETYLCHOLINE 
coronary atherosclerosis to assess the response to acetylcholine 
over multiple sequential segments of the same coronary artery. 
The results of this study have been presented previously in 
preliminary form (15). 
Methods  
Patient selection, demographics and characteristics. Pa- 
tients with a history of chest pain and mildly positive exercise 
treadmill tests were enrolled in a protocol approved by the 
Investigational Review Board of the University of California 
San Diego, School of Medicine and the Veterans Affairs 
Medical Center, San Diego. Informed consent was obtained in 
writing from all subjects. Subjects with a recent myocardial 
infarction, unstable angina, variant angina, congestive heart 
failure, severe peripheral vascular disease or severe coronary 
disease by coronary angiography were excluded. 
The study group comprised 31 patients (28 men, 3 women; 
mean age 60 years, range 32 to 73), 16 of whom had a history 
of hypertension, 26 were tobacco smokers (5 active, 22 
former), and 4 had a history of diabetes mellitus. Mean total 
cholesterol was 244 mg% (range 192 to 308), mean low density 
lipoprotein cholesterol was 175 rag% (range 105 to 226), and 
mean high density lipoprotein cholesterol was 48 rag% (range 
33 to 67). A single coronary artery was selectively studied in 
each patient (left anterior descending coronary artery in 26 
patients, left circumflex coronary artery in 5). All patients had 
mild atherosclerotic coronary disease, as manifested by lumen 
irregularities or significant stenosis of a studied or nonstudied 
coronary artery, respectively. No artery studied had a diameter 
stenosis >50% by angiography. 
Protocol and methods. All antianginal therapy was discon- 
tinued at least 24 h before the catheterization and angio- 
graphic procedure. After diagnostic atheterization, a 3F infu- 
sion catheter was placed subselectively through a standard 8F 
guiding catheter into the proximal segment of the coronary 
artery to be studied; right atrial pacing at 80 beats/min was 
then established by an electrode catheter. Biplane coronary 
angiography was performed in the control state and after serial 
3-min infusions by a Harvard pump of acetylcholine at con- 
centrations of 10 -6, 10 -5 and 10 -4 tool/liter. Assuming a 
coronary artery flow of 80 ml/min, intracoronary acetylcholine 
concentrations were 10 8, 10-7, and 10 6 tool/liter, respec- 
tively. All 31 patients received the three doses of acetylcholine. 
Coronary arteriography was performed by an electrocardio- 
graphic (ECG)-gated power injection of 9 ml of nonionic 
contrast agent (Omnipaque 350, Winthrop-Breon Laborato- 
ries) at 6 ml/s using a Medrad Mark IV injector (Medrad Inc.). 
Multiple control injections during saline infusion were per- 
formed in 17 patients (11 of whom subsequently participated in
the acetylcholine protocol) for determination of the reproduc- 
ibility limits of repeated measurements of coronary artery 
dimensions. 
All images were acquired maintaining identical X-ray gan- 
try, table height and source-to-image intensifier distance (i.e., 
the magnifications and projections were maintained constant 
throughout the imaging sequences). Projections were selected 
to 1) optimally display the maximal length of the vessel parallel 
to the image plane so as to minimize foreshortening (Fig. 1); 
2) minimize superimposition of branches and other arteries; 
and 3) minimize overlap of the artery with the diaphragm, 
spine and lung field. Before injection of iodinated contrast 
agent, fluoroscopic images were used to confirm visualization 
of the guiding catheter tip in the image field. The catheter was 
initially imaged while unopacified by contrast. At study end, 
the catheter tip was measured using electronic alipers to 
calibrate the magnification for each contrast injection. 
Cine frame selection and image digitization. All cineangio- 
graphic images were acquired during held inspiration at 30 
frames/s in the 6-in (15-cm) magnification mode of the image 
intensifier. An ECG trigger was used to identify the QRS onset 
and to mark the corresponding cine frames. Images were 
displayed by a General Electric CAP-35 cine projector inter- 
faced to a Cohu CCD camera with a Fujinon zoom lens (10:1). 
The camera system's focus, iris and zoom were remotely 
controlled. For each patient, frames from each contrast injec- 
tion (after control and acetylcholine infusions) were selected to 
be in the same phase of the cardiac ycle (usually end-diastole) 
so as to visualize the whole or nearly all of the selected 
coronary artery. Frames that showed optimal opacification of 
the vessel were then digitized using a Gould DeAnza IP8500 
image-processing system interfaced to a micro VAX II (Digital 
Equipment Corp.) at a resolution of 512 × 512 pixels (magni- 
fication of 112 _+ 23 [mean _+ SD]/xm/pixel, 8bits, 256 shades 
of gray). The artery under study was ultimately constituted by 
capturing different but overlapping frames from the same 
contrast injection. Video gain and offset were adjusted to 
utilize maximally the analog voltage range of the video digi- 
tizer. Oversaturation a d undersaturation f video levels were 
avoided by utilizing a special video look-up table. 
Quantitative coronary angiography: edge detection, frame 
splicing and annotation. Coronary artery quantification i the 
present study was based on a geometric approach utilizing 
single-plane views. From the biplane images, the images that 
optimized the projection described earlier were chosen for 
analysis. An automatic detection routine was utilized to deter- 
mine vessel edges, but manual editing was utilized when 
necessary. A gradient image was created using a Sobel opera- 
tor; then a maximal ikelihood matrix, based on the gradient 
and the raw X-ray images, was created and used to define an 
estimate of the edges. Based on weighted first- and second- 
derivative thresholds, a correction was applied to define the 
edges. This algorithm is based on a method proposed by 
Dijkstra (16). Once edges were established, a centerline was 
computed as the midpoints of the shortest distances between 
corresponding points on either edge as the interrogation 
proceeds along the coronary artery. The lengths of chords 
perpendicular to the centerline between both edges were 
defined and plotted as successive diameters. We validated the 
edge detection algorithm on Plexiglas, contrast-filled vessel 
phantoms with diameters ranging from 0.5 to 6 ram; the 
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Figure 1. Spliced image of a left anterior descending 
coronary artery (three separate end-diastolic frames) 
with superimposed vessel edges determined byedge- 
recognition algorithm, annotated branch points and 
beginning and end points of diameter function. See text 
for details. 
measured and actual diameter values correlated with an r value 
of 0.99. 
The operator annotated all of the anatomic fiducial points 
on the centerline: 1) vessel branch points; 2) overlapping or 
foreshortened regions to be excluded from analysis; 3) com- 
mon points between different images to be used to reconstruct 
the full composite image for the whole vessel; and 4) the 
beginning and end points. These annotations were subse- 
quently used for splicing together two to four diameter arrays 
and image segments by autocorrelation of centerline and 
image segments for common parts of the vessel. All images and 
diameter sequences were reconstructed to yield one full image 
(Fig. 1) as well as one single array of diameters. 
Smoothing and interpolation. Each diameter array was 
smoothed using a 20-point moving average filter. For each of 
the four diameter arrays (control and three levels of acetylcho- 
line) in a given patient, the number of diameters between 
branch points was not identical. To compare data from these 
four diameter arrays, linear interpolation was performed on 
the data acquired uring the infusion of the three levels of 
acetylcholine. All diameter arrays, between fiducial branch 
points, then had the same number of data points as on 
corresponding segments of the control angiogram (Fig. 2). 
After interpolation, the data were partitioned into segments of 
50 diameters each that were then averaged to allow regional 
analysis of the vessel. Any vessel segment with marked fore- 
shortening or overlap with other arteries was excluded. 
Statistical analysis: variance of multiple control injections. 
To analyze each arterial segment independently of others in 
the same artery or in other patients, the reproducibility of 
sequential injections was determined (17,18). Three successive 
control angiograms were performed at 3-min intervals in 17 
patients, 1l of whom subsequently also participated in the 
acetylcholine protocol. Measurements of the selected artery 
from these injections were then subjected to interpolation, 
smoothing and partitioning into segments, as described earlier 
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Figure 2. Top, Vessel diameter (mm) versus length (cm) functions for 
two successive control injections. Note slight change in overall ength 
and lack of registration of branch points. Bottom, Same curves as in top 
panel; control A has now been interpolated to control B to effect 
anatomic registration of beginning point, end point and definable 
branch points. 
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Figure 3. Top, Vessel diameter (ram) versus length (cm) functions 
(interpolated and smoothed) for three successive control injections. 
Bottom, Same curves as in top panel; sequential 50-point bins have 
been averaged as segments. 
(Fig. 3). The averages of the diameters of corresponding 
50-point segments were then subtracted from each other (i.e., 
A - B, B - C and C - A), and the standard eviation of these 
differences was found to be 0.153 ram. Thus, the limit of 
detection of a significant change from control diameter was 
established as a change in diameter of at least 0.31 mm 
(->2 SD). 
Results 
Quantitative analysis. The length of arte~ analyzable in 
the 31 study patients ranged from 3.4 to 9.3 cm (mean [_+SD] 
5.7 _+ 1.3), corresponding to 5 to 21 segments (mean 11.3 _+ 
3.5) of 5.6 + 1.1 mm/segment per patient. Analysis of the distal 
vessel was terminated when background interference or vessel 
overlap precluded accurate dge detection; the mean diameter 
of the most distal segment measured in each patient was 
1.34 + 0.46 ram. After exclusion of segments for technical 
reasons (vessel overlap, foreshortening, poor opacification), 
349 (94%) of 367 total segments were analyzed uring control 
infusion and each concentration of acetylcholine. 
Response to acetylcholine infusion. The change in mean 
vessel diameter versus control in all segments from each 
patient demonstrated a logarithmic dose-response relation 
(Fig. 4, top). Mean change in vessel diameter was -0.036 + 
0.011 mm on infusion of 10 -6 mol/liter of acetylcholine; 
-0.074 + 0.013 mm on infusion of 10 -5 tool/liter; and -0.024 _+ 
0.018 mm on infusion of 10 -4 tool/liter, with percent change 
from control of -1.39 _+ 0.63%, -3.41 _+ 0.73% and -5.86 _+ 
0.91%, respectively (all mean _+ SEM). However, these mean 
values include individual segments with disparate responses to 
acetylcholine. Using the definition of a significant vasomotor 
response as ->0.31-ram change from control vessel diameter, 
vasodilation was demonstrated on infusion of 10 -4 tool/liter of 
acetylcholine in 24 (6.9%) of 349 segments, vasoconstriction in 
86 (24.6%) and no response in 239 (68.5%) (Fig. 4, bottom). 
At lower doses of acetylcholine, fewer significant vasomotor 
changes were seen. With 10 .5 tool/liter of acetylcholine vaso- 
dilation was found in 18 segments (4.9%), vasoconstriction i  
49 (14.0%) and no response in 283 (81.1%). With 10 -6 
tool/liter of acetylcholine vasodilation was demonstrated in 15 
segments (4.3%), vasoconstriction i 25 (7.2%) and no re- 
sponse in 309 (88.5%). 
Vasomotor esponses were demonstrated not only in prox- 
imal but also in distal segments, with significant vasoconstric- 
tion seen up to 7.3 cm distal to the infusion site in one patient 
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Figure 4. Top, Logarithmic dose-response r lation of average seg- 
mental diameter change from control state (mm) on infusion of 
acctylcholine (ACH) over the dosage range of 10 -6 to 10 4 mol/liter. 
Bottom, Dose-response r lation of percent of all segments studied 
exhibiting a significant vasodilator or vasoconstrictor response to 
acctylcholine over the dosage range of 10 6 to 10 4 tool/liter. Note 
that the greatest frequency of vasodilator as well as vasoconstrictor 
responses i seen at the 10 4 mol/liter dose. 
at the acetytcholine 10 -4 tool/liter dose. Because of variation 
in artery length, the total number of segments cumulatively 
analyzed ecreased with distance from the assigned beginning 
point along the vessel, but the proportion of segments demon- 
strating significant change did not (Fig. 5). 
Pattern of response to acetylcholine. At the acetylcholine 
10 4 mol/liter dose, only 4 (13%) of the 31 patients howed a 
homogeneous response in all segments, and in each of these 
patients all segments demonstrated no significant change (Fig. 
6 [top], Table 1). The response to acetylcholine was heteroge- 
neous in the other 27 patients (87%). Fourteen patients had 
some segments that vasoconstricted and other segments that 
showed no change; seven had segments that vasodilated and 
other segments that showed no change; and six had segments 
that demonstrated vasoconstriction and other segments that 
demonstrated vasodilation. A heterogeneous pattern of re- 
sponse was seen in 20 patients (65%) at the 10 -5 tool/liter dose 
of acetylcholine and in 19 patients (61%) at the 10 -6 mol/liter 
dose (Table 1). Again, all of the homogeneous responses seen 
were in patients who demonstrated nosignificant change in any 
segment. When the response to acetylcholine atall three doses 
was combined, 29 (94%) of the 31 patients demonstrated a 
heterogeneous pattern, and 14 (45%) had both significantly 
dilated segments and significantly constricted segments in the 
same artery (Fig. 6, bottom). 
Dosage correlations. Comparison of the lowest with the 
highest doses of acetylcholine demonstrated concordant re- 
sponses in 252 (73%) of 349 segments; either significant 
vasodilation was seen at both doses (Fig. 7, area VD6/VD4) or 
there was no change (center area) or vasoconstriction was seen 
at both doses (VC6/VC4). In no segment did acetylcholine at 
10 -6 mol/liter give rise to significant vasodilation, whereas 
10 -4 mol/liter caused vasoconstriction, or vice versa (discor- 
dant responses, areas VD6/VC4 and VD4/VC6). Of 349 seg- 
ments, vasodilation at high dose in segments with no change at 
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Figure 5. Percent of vessel seg- 
ments at a given position along 
the coronary artery that exhibit 
significant dilation (hatched bars) 
or constriction (shaded bars) on 
infusion of acetylcholine (ACH) 
(10 4 mol/liter). Segment 1 was 
closest o the tip of the infusion 
catheter, with larger segment 
numbers uccessively more distal. 
Numbers above bars denote total 
number of segments ateach posi- 
tion. Artery lengths varied by pa- 
tient. Vasomotion was not related 
to segment position. 
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Figure 6. Top, Plot of absolute 
change (mm) from control diameter 
of vessel segments of each study 
patient on acetylcholine (ACH) 
10 4 re•l/liter infusion. Patients are 
grouped by categories of response. 
Shaded area represents control re- 
producibility limits. A heteroge- 
neous response was seen in 27 of 31 
patients, and all four homogeneous 
responses correspond to no change 
in any segment. Bottom, Plot of 
absolute change (mm) from control 
diameter of vessel segments of each 
study patient, with responses from 
acetylcholine 10 6, 10 5 and 10 4 
re•l/liter infusions combined and 
superimposed. Patient numbers as 
in top panel. When all doses were 
combined, all but two patients ex- 
hibited a heterogeneous response to 
acetylcholine; dilation and signifi- 
cant constriction were seen in the 
same vessel in 14 (45%) of 31 pa- 
tients. 
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low dose was seen in 17 segments (5%, area VD4/NC(,), 
whereas high dose vasoconstriction with no change at low dose 
was noted in 59 segments (17%, area  VC4/NC6) .  Vasodilation 
at low dose only, with no change at high dose, was seen in nine 
segments (2%, area VD~C4) .  
Discuss ion 
Coronary artery dilation in response to acetylcholine im- 
plies the normal release of endothelium-derived r laxing factor 
(EDRF); a vasoconstrictor effect results when endothelium- 
derived relaxing factor action is impaired, and direct 
acetylcholine-induced constriction of vascular smooth muscle 
becomes manifest (1-14). In many studies (5,9,11,13,14), pa- 
tients have been classified as demonstrating a constrictor or 
dilator effect of acetylcholine on the basis of a percent change 
in mean vessel diameter in a single segment of the vessel 
(2 mm to 2 cm in length) compared with that after a control 
coronary arteriographic injection; heterogeneity of response 
then reflects the variable and opposite ffects een in different 
patients. Previous studies (8,9,16) that correlated coronary 
artery disease risk factors to coronary endothelium-dependent 
vasomotion reported analysis of only a single, short area of the 
artery and excluded potentially disparate data from other 
arterial segments. Data presented here indicate that the re- 
sponse to acetylcholine is heterogeneous, with disparate re- 
sponses often noted in different segments of the same vessel 
(Fig. 8). Vasomotor esponses can occur at almost any point 
along the vessel and may vary with acetylcholine concentration. 
Thus, classification of patients as manifesting vasoconstriction 
or vasodilation is dependent on the amount of vessel analyzed, 
method of selection of segments, dose of acetylcholine deliv- 
ered and degree of reproducibility in imaging and quantitating 
arterial dimensions. 
Approach to quantitative coronary angiography. Our com- 
puter software quantitates the dimensions of multiple contig- 
uous segments of a coronary artery or a large proportion of any 
given vessel (Fig. 1). A continuous diameter function, extend- 
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Table 1. Vascular Responses to Acetylcholine 
Acetylcholine Dose (mol/qiter) 
Response 10 6 10 5 10 4 
Heterogeneous 
Vasodilation and no change 5 5 7 
Vasodilation and 5 3 6 
vasoconstriction 
Vasoconstriction and no change 9 12 14 
Total 19 (61%) 20 (65%) 27 (87%) 
Homogeneous 
All vasodilation 0 0 0 
All vasoconstriction 0 0 0 
All no change 12 11 4 
Total 12 (39%) 11 (35%) 4 (13%) 
o15 1 115 2 215 J 3~5 4 415 5 515 6 615 7 715 8 815 9 915 l0 
Vessel Length (em) 
ing from a proximal beginning point to an end point (both 
operator determined), is obtained by splicing autocorrelated 
digital cine frames imaged at the same time in the cardiac ycle 
(usually end-diastole). To ensure that dimensional changes 
were analyzed in corresponding loci, an interpolation routine is 
applied that either contracts or expands local, successive 
measurements so that beginning, end and branch points cor- 
respond within the whole diameter function (Fig. 2). Because 
each linear interpolation is carried out between two successive 
diameter measurements, further smoothing of the final diam- 
eter function occurs, but the measured and calculated iame- 
Figure 7. Change in segment dimension with 10 ~ mol/liter of acetyl- 
choline (AAch 6) versus 10-4 tool/liter (AAch 4). Gray areas represent 
reproducibility limits for detection of a significant change. Note that 
most responses do not represent a significant vasomotor change at 
both high and low dose infusions of acetylcholine. NC4, NC 6 = no 
change with 10 4 and 10 ~ mol/liter of acetylcholine; VC4, VCo - 
vasoconstriction with 10 -4 and 10 6 mol/liter of acetylcholine; VD4, 
VD 6 = vasodilation with 10 4 and 10 6 tool/liter of acetylcholine. 
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Figure 8. Top, Vessel diameter (ram) versus length (cm) functions 
(interpolated and smoothed) for control and acetylcholine (10 4 
tool/liter) infusions. Functions are shown after interpolation and 
splicing but before 50-point bin averaging. Bottom, Vessel diameter 
(mm) versus length (era) functions after 50-point bin averaging of 
curves in top panel Constriction and dilation in the same artery are 
indicated. 
ter values (noninterpolated vs. interpolated) perforce differ by 
less than the difference between two successive values. Thus, 
the algorithm changes the profile but not the accuracy of the 
overall diameter function. We believe that this approach 
ensures that differences in segment dimension brought about 
by pharmacologic challenge are calculated over the same and 
corresponding anatomic loci. 
Statist ical analysis of  d imens iona l  data. Assessment of the 
effects of acetylcholine on coronary dimensions, compared 
with those in a control state, requires multiple, successive 
radiographic films exposed while the patient is held in a 
constant position. Simple calculation of the percent change of 
arterial dimension from baseline does not allow for change 
caused by the inherent limit of reproducibility of the quanti- 
tative angiographic method (19,20). Moreover, this variability 
may be different for an obstruction, as opposed to a reference, 
diameter. Reiber and Serruys (20) found a minimal threshold 
value for the occurrence of "vasomotor changes at the individ- 
ual patient level (95% confidence interval)" to be 0.47 mm for 
JACC gol. 25, No. 5 PENNY ET AL. 1053 
April 1995:1046-55 CORONARY ARTERY RESPONSE TO ACETYLCHOLINE 
an obstruction but 0.35 mm for a reference diameter. This 
latter eproducibility limit is very close to the 95% confidence 
interval of 0.31 mm obtained from control patients in this 
investigation. 
Methodologic variability might be overcome by comparing 
groups of measurements, where differences <0.31 mm may be 
statistically significant. However, grouping data is complicated 
because different arterial segments from the same patient or 
from different patients may respond independently, and this 
variability may be obscured in a group average. Thus, when 
single arterial segments are compared independently, webe- 
lieve that he 95% confidence interval for detecting a change in 
diameter is -0.31 ram; smaller changes cannot be detected 
using current echniques. 
A potential limitation of our approach is the use of an 
absolute diameter change (_+0.31 ram) as the definition of 
significant vasomotion. This means that in a segment averaging 
3.0 mm in diameter, slightly more than a 10% change in 
diameter would be considered significant, whereas in a 1.0-mm 
vessel, a 31% change would be required. A given percent 
change in diameter thus could be classified as significant in one 
segment but as no change in a smaller segment. However, the 
absolute 95% confidence limit of _+0.31 mm represents an 
average reproducibility limit for vessels of all sizes; the use of 
this standard was necessary to distinguish physiologic hetero- 
geneity of response from that engendered byvariability in the 
method of detection itself (Fig. 6). Despite this, when the 
vasomotor effect of acetylcholine was expressed as a percent 
change from control vessel diameter, a heterogeneous pattern 
also was observed. 
Acetyleholine responses: regional and dose-related consid- 
erations. Using the previously described methods and repro- 
ducibility limit, there was a heterogeneous pattern of response 
to acetylcholine: 27 of 31 patients howed a difference in 
categorization of segmental dimensional changes within the 
same vessel. Variable vasomotor responses could occur at 
almost any site along the vessel, and there was no consistent 
type of response in the more distal compared with the more 
proximal segments. The change in a given artery's dimensions 
was heterogeneous in response to the dose of acetylcholine 
administered. A heterogeneous re ponse was seen in 29 of 31 
patients when data from all three doses were included. In 45% 
of patients there was significant constriction of at least one 
segment and significant dilation of another segment in the 
same vessel. Although comparison of low and high dose 
acetylcholine showed no discordant responses (Fig. 7), many 
segments exhibited a significant change at one dose but no 
change at another. Segments that demonstrate no change at 
any dose of acetylcholine may be truly inert or may undergo a
change too small to be detected by our method. Alternatively, 
segments demonstrating o change at low dose only may be 
understimulated by acetylcholine, and there may be an inter- 
mediate stage in which marginally dysfunctional endothelium 
is unable to mediate dilation but can still counterbalance the 
direct constrictive ffect of acetylcholine on smooth muscle. 
Over a range of doses, this balance may be altered, with, for 
instance, a higher dose of acetylcholine stimulating more 
endothelium-derived r laxing factor release and producing 
dilation in place of no change where normal endothelium is 
present or, conversely, stimulating more direct smooth muscle 
effect that overcomes a limited endothelium-derived r laxing 
factor effect in regions of abnormal endothelium. A direct 
vasoconstrictor effect of acetylcholine that may override ven 
normal endothelial function has been described at higher doses 
(10 -3 mol/liter) than those used in this study (21). We suspect 
that this effect was not seen here because of the linear, 
incremental dose-response r lation and the induction of sig- 
nificant vasoconstriction i only 25% of segments at the 
highest acetylcholine dose. 
This dose-related and regional heterogeneity of response to 
acetylcholine underscores the importance of analyzing seg- 
ments independently and distinguishing significant vasomotor 
responses from those resulting from inherent variability of the 
method. Ideally, the vessel should be partitioned into segments 
short enough so that focal diameter changes are not "averaged 
out" by the adjacent nonreactive ssel. As much of the vessel 
length as technically possible should be included for analysis, 
because significant changes may occur at any point along the 
artery, and the heterogeneous re ponse to acetylcholine pre- 
cludes assumption of the nature of the effect on any segment 
not specifically analyzed. 
Previous tudies. Horio et al. (2) described in patients with 
minimal diameter narrowing a variable response along the 
course of the coronary artery when exposed to intracoronary 
acetylcholine in doses of 30, 50 and 100/zg. Proximal, middle 
and distal portions of the coronary arteries were sampled at the 
site showing maximal vasoconstriction or vasodilation, and 
percent dimensional changes were assessed by electronic ali- 
pers. In those patients undergoing left anterior descending 
coronary artery analysis, the proximal and middle regions 
showed only constriction or no change with all doses of 
acetylcholine. Different responses among arterial segments in 
the same artery in the same patient were not reported, and 
intercontrol variability was not described. Similarly, Vita et al. 
(6) described marked change in some vessel regions and 
minimal change in others in response to acetylcholine, but they 
did not report marked constriction and dilation within the 
same vessel. They subsequently noted vasoconstriction at 
branch points with slight dilation in straight segments (13). 
Intercontrol variability was not reported in either study. 
Yasue et al. (7) reported on the response to acetylcholine in
49 patients with a normal coronary angiogram and in 25 
patients with signs of coronary atherosclerosis. In patients with 
disease, as well as patients of advanced age without coronary 
disease, vasoconstriction with acetylcholine was noted, partic- 
ularly in proximal segments of the artery. However, none of 
their patients exhibited both vasoconstrictor and vasodilator 
responses in the same artery. 
Recently, El-Tamimi et al. (22) described acetylcholine 
vasomotor responses, quantitated by a cinevideodensitometric 
technique, in 28 patients with coronary artery disease (one- to 
three-vessel disease, lesions >50% diameter stenosis). At least 
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six segments were analyzed in each patient and then averaged 
over proximal, middle and distal regions of the artery. Al- 
though a reproducibility limit was not explicitly defined, at 
least a ---10% diameter change compared with control diame- 
ter was required to define segmental constriction or dilation. In 
the left anterior descending coronary branch, acetylcholine 
(10 -4 tool/liter) produced vasoconstriction i  all segments in 
21 (75%) of 28 patients. In the remaining seven patients, the 
response was variable, with some segments vasoconstricting 
and some dilating in the same artery. In three of the seven 
patients the response was variable in the left anterior descend- 
ing coronary artery, whereas in five patients undergoing study 
of the left circumflex coronary artery all proximal and middle 
segments constricted, and all five distal segments dilated with 
acetylcholine (10 -4 tool/liter); individual responses to lower 
doses were not reported. 
These previous tudies upport he variability of responses 
to acetylcholine between patients, between vessels and at 
selected sites along the same vessel, although these investi- 
gations have not assessed vasomotion at multiple, sequential 
sites along the vessel or based the analysis on a 95% confidence 
limit for reproducibility of control measurements. Our data 
fail to confirm proximal and midvessel constriction versus 
distal dilation as the major type of single-vessel heterogeneity 
(2,22). 
Implications and conclusions. Previous experimental as 
well as clinical observations suggest hat vasodilation in re- 
sponse to acetylcholine stimulation ismediated by endothelium- 
derived relaxing factor, a response that may be compromised 
by early endothelial involvement by atherosclerosis. In the 
setting of endothelial dysfunction, the direct muscarinic effect 
of acetylcholine becomes dominant, and vasoconstriction re- 
suits. Therefore, avasoconstrictor response may constitute an 
early marker of atherosclerosis not detectable by other means. 
Because of the nonuniform development of atherosclerosis 
along the course of a given artery, regional differences in 
endothelial dysfunction would most likely explain the hetero- 
geneity in response noted in this investigation. 
Hypothetically, the heterogeneous re ponse in the coronary 
arteries of our patients may have been related to an inconstant 
density or distribution of the number and types of muscarinic 
receptors. However, this hypothesis i  unproved because, to 
our knowledge, no studies exist hat definitively quantitate he 
subtypes and density of muscarinic receptors, both transmu- 
rally and longitudinally, along the human coronary artery. 
Moreover, these receptors might vary with age, coronary risk 
factors or naturally among patients. Other locally vasoactive 
substances elaborated in the endothelium (e.g., endothelin, 
leukotriene, prostacyclin) also may have affected the direct 
influence of acetylcholine on coronary tone. 
The demonstration in this patient group of a heteroge- 
neous response to intracoronary acetylcholine confirms that 
this pharmacologic test of endothelial integrity is not con- 
sistent in all regions of a given coronary artery and may, in 
fact, be opposite in different segments of the same artery. 
Moreover, when a definition of segmental change based on 
methodologic variability is applied, most individual coro- 
nary segments do not exhibit a statistically significant change 
of dimension with acetylcholine challenge. Studies in which 
responses of a single segment (or even several segments) are 
examined may not provide results representative of the 
entire vessel. Inclusion of the entire analyzable region of a 
coronary artery and establishment and application of the 
limit of reproducibility of the quantitative angiographic 
system used are essential for optimal assessment of segmen- 
tal coronary vasomotor response. 
Wc acknowledge the recruitment and organizational ssistance ofJoanna Smith, 
RN and Susan Ueland, RN and the computer programming assistance of Josh 
Peterson, BS. 
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